Penicillin V

CHEMBL615 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
350.4 g/mol
LogP
2.1
Phase
4

Acid stability is what allows penicillin V to be given by mouth where benzylpenicillin cannot, and that property defines its clinical niche. The agent treats mild to moderate bacterial infections, streptococcal pharyngitis and skin infections among them, acting through the beta-lactam mechanism common to the class: interference with the cross-linking of peptidoglycan leaves the bacterial cell wall unable to withstand internal osmotic pressure. Its spectrum is narrower than that of the aminopenicillins and it offers no protection against beta-lactamase-producing staphylococci. The compound is a small molecule with formula C16H18N2O5S and a molecular weight of approximately 350.4 g/mol. It is approved and has completed the final phase of clinical development.

This oral penicillin antibiotic treats mild to moderate bacterial infections such as strep throat and skin infections.

आणविक भार

350.4000 g/mol

LogP

2.10

TPSA

121.00 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O

InChI

InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1

Molecular Formula

C16H18N2O5S

HBD / HBA

2 / 6

घूर्णनीय बंधन

5

भारी परमाणु

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

This oral penicillin antibiotic treats mild to moderate bacterial infections such as strep throat and skin infections.

Yes, Penicillin V is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL615. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6869. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.